RG
DPLO

Renaissance Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Renaissance Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-9,322
Closed -$255K – 290
2016
Q1 		$255K Sell
9,322
-256
-3% -$7.54K 0.01% 254
2015
Q4 		$328K Buy
+9,578
New +$299K 0.01% 185

Other funds holding DPLO

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Renaissance Group's DPLO Position: Q2 2016 in Review

Renaissance Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2016, closing a stake of 9,322 shares — an estimated $255K sold.

Renaissance Group first reported a position in DPLO in Q4 2015 and held it in 2 quarters. The position peaked at $328K in Q4 2015. 166 funds tracked by Wall St. Rank hold DPLO as of Q2 2016.

  • Renaissance Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2016 after selling out during the quarter.
  • Renaissance Group sold 9,322 DIPLOMAT PHARMACY, INC. shares in Q2 2016, an estimated $255K.
  • Renaissance Group first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and held it in 2 quarters.
  • Renaissance Group's DIPLOMAT PHARMACY, INC. position peaked at $328K in Q4 2015.
  • 166 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2016.

Based on Renaissance Group's 13F filing for Q2 2016, filed 10 Aug 2016.